ClinVar Miner

Submissions for variant NM_014000.3(VCL):c.874+13T>C

gnomAD frequency: 0.00001  dbSNP: rs777617736
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000600292 SCV000731529 likely benign not specified 2017-02-22 criteria provided, single submitter clinical testing c.874+13T>C in intron 7 of VCL: This variant is not expected to have clinical si gnificance because it is not located within the splice consensus sequence. It h as been identified in 3/11416 Latino chromosomes by the Exome Aggregation Consor tium (ExAC, http://exac.broadinstitute.org; dbSNP rs777617736).
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000600292 SCV001623234 benign not specified 2021-05-10 criteria provided, single submitter clinical testing Variant summary: VCL c.874+13T>C alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 4e-05 in 251016 control chromosomes. The observed variant frequency is slightly higher than the estimated maximal expected allele frequency for a pathogenic variant in VCL causing Cardiomyopathy phenotype (2.5e-05), suggesting that the variant may be benign. To our knowledge, no occurrence of c.874+13T>C in individuals affected with Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign.
Invitae RCV002060629 SCV002364407 likely benign Dilated cardiomyopathy 1W 2024-01-25 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.